While some findings suggest an increased risk of hepatic steatosis and fibrosis in acromegaly, others indicate a protective effect of GH against lipid accumulation in the liver, which complicates the assessment of potential bidirectional associations between acromegaly and MASLD. Here, GH1 is linked to metabolic dysfunction-associated steatotic liver disease.